Lowe David A 4
4 · MEMORY PHARMACEUTICALS CORP · Filed Jan 5, 2009
Insider Transaction Report
Form 4
Lowe David A
DirectorChief Scientific Officer
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−26,316$16,053→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-01-05$0.06/sh−300,000$18,000→ 300,000 totalExercise: $0.55Exp: 2018-01-31→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option, which provided for quarterly vesting over four years commencing on the grant date, was canceled in connection with the Issuer's merger with 900 North Point Acquisition Corporation on January 5, 2009. In exchange, the Reporting Person received a cash payment of $18,000, which represents the difference between the exercise price of the option and the offer price of $0.61 per share multiplied by the number of shares underlying the option.